Rituximab in ME/CFS: a randomised, double-blind and placebo-controlled trial
Professor Øystein Fluge
Haukeland University Hospital, Bergen, Norway

Oystein Fluge received medical degree in 1988 at the University of Bergen, and is a specialist in oncology since 2004.

He has worked as a Research Fellow with support from the Norwegian Cancer Society and is now chief physician at the Cancer Department, Haukeland University Hospital.

Doctoral work emanates from the Surgical Institute and Department of Molecular Biology, University of Bergen.